Vincerx Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 631,397 | $165,931 | 0.00% | 1.38% |
| VANGUARD GROUP INC | 02/11/2025 | 286,372 | $75,315 | -54.36% | 0.63% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 241,517 | $63,489 | -3.70% | 0.53% |
| UBS GROUP AG | 02/14/2025 | 92,779 | $24,401 | 38,882.77% | 0.20% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 22,100 | $5,808 | -66.52% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 21,371 | $5,616 | -33.17% | 0.05% |
| JANE STREET GROUP, LLC | 02/14/2025 | 11,190 | $2,941 | -46.47% | 0.02% |
| SAGE RHINO CAPITAL LLC | 02/06/2025 | 1.70 M | $447,657 | 0.00% | 0.01% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 891,719 | $234,344 | 0.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 567,011 | $149,010 | -79.03% | 0.00% |
| RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 116,873 | $30,714 | 0.00% | 0.00% |
| HRT FINANCIAL LP | 02/14/2025 | 59,804 | $15,000 | 306.80% | 0.00% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 47,080 | $12,373 | 0.00% | 0.00% |
| COLONY GROUP, LLC | 02/14/2025 | 10,900 | $2,865 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 23 | $6 | -60.34% | 0.00% |
| BANK & TRUST CO | 01/07/2025 | 1,000 | $263 | 0.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PROSIGHT MANAGEMENT, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vincerx Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 32 institutional investors and hedge funds held shares of Vincerx Pharma, Inc.. The most heavily invested institutionals were:
SAGE RHINO CAPITAL LLC: 1.7 M
Rock Springs Capital Management LP: 891,719
GOLDMAN SACHS GROUP INC: 631,397
ARMISTICE CAPITAL, LLC: 567,011
VANGUARD GROUP INC: 286,372
GEODE CAPITAL MANAGEMENT, LLC: 241,517
0.03% of Vincerx Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.82 M shares in the last 24 months. This purchase volume represents approximately $1.01 M in transactions.